Changes in Depression and Anxiety in a Randomized, Double-blind, Placebo-controlled Study of Galcanezumab in Adults with Treatment-resistant Migraine: Results from the CONQUER Study

被引：0
|
作者：
Maizels, Morris [1 ]
Buse, Dawn C. [2 ]
Jedynak, Jakub [3 ]
Hand, Austin L. [4 ]
Ford, Janet [3 ]
Detke, Holland [3 ]
机构：
[1] Providence St Joseph Hlth, Renton, WA USA
[2] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IQVIA, Durham, NC USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1383
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled study
    Li, Howard J.
    Martinez, Pedro E.
    Li, Xiaobai
    Schenkel, Linda A.
    Nieman, Lynnette
    Rubinow, David
    Schmidt, Peter J.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2020, 23 (03) : 401 - 412
  • [42] A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder
    Gharabawi, G. M.
    Canuso, C. M.
    Pandina, G. J.
    Bossie, C. A.
    Kujawa, M.
    Kosik-Gonzalez, C.
    Turkoz, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S562 - S562
  • [43] A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder
    Gharabawi, G.
    Canuso, C.
    Pandina, G.
    Bossie, C.
    Kujawa, M.
    Kosik-Gonzalez, C.
    Turkoz, I.
    Papakostas, G. I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S236 - S236
  • [44] Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study
    Yuan, Hsiangkuo
    Curran, John G.
    Keith, Scott W.
    Hopkins, Mary M.
    Silberstein, Stephen D.
    HEADACHE, 2021, 61 (09): : 1432 - 1440
  • [45] Treatment of Comorbid Migraine and Temporomandibular Disorders: A Factorial, Double-Blind, Randomized, Placebo-Controlled Study
    Goncalves, Daniela A. G.
    Camparis, Cinara M.
    Speciali, Jose G.
    Castanharo, Sabrina M.
    Ujikawa, Liliana T.
    Lipton, Richard B.
    Bigal, Marcelo E.
    JOURNAL OF OROFACIAL PAIN, 2013, 27 (04): : 325 - 335
  • [46] Intravenous Ibuprofen for Acute Migraine Treatment: A Double-Blind Randomized Placebo-Controlled Pilot Study
    Curran, John
    Yuan, Hsiangkuo
    Keith, Scott
    Hopkins, Mary
    Silbertstein, Stephen
    NEUROLOGY, 2022, 98 (18)
  • [47] Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
    Noruzzadeh, Rezvan
    Modabbernia, Amirhossein
    Aghamollaii, Vajiheh
    Ghaffarpour, Majid
    Harirchian, Mohammad Hossein
    Salahi, Sarvenaz
    Nikbakht, Nikta
    Noruzi, Nahid
    Tafakhori, Abbas
    HEADACHE, 2016, 56 (01): : 95 - 103
  • [48] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [49] Efficacy of phenazone in the treatment of acute migraine attacks:: a double-blind, placebo-controlled, randomized study
    Göbel, H
    Heinze, A
    Niederberger, U
    Witt, T
    Zumbroich, V
    CEPHALALGIA, 2004, 24 (10) : 888 - 893
  • [50] Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: A double-blind, randomized, placebo-controlled study
    Zhang, Zhang-Jin
    Kang, Wan-Hu
    Li, Qiang
    Wang, Xue-Yi
    Yao, Shao-Min
    Ma, Ai-Qun
    SCHIZOPHRENIA RESEARCH, 2006, 88 (1-3) : 102 - 110
12345